PIRAMAL PHARMA SOLUTIONS SUPPORTS THERACOSBIO WITH INTEGRATED DRUG SUBSTANCE/DRUG PRODUCT PROGRAM FOR BEXAGLIFLOZIN ...Middle East

TheracosBio recently received FDA approval for Brenzavvy™ (bexagliflozin), an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor Piramal supported TheracosBio with starting materials, active pharmaceutical ingredient (API), and oral solid dosage formulation Integrated drug development...

Hence then, the article about piramal pharma solutions supports theracosbio with integrated drug substance drug product program for bexagliflozin was published today ( Thursday 30/03/2023 - 11:24 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( PIRAMAL PHARMA SOLUTIONS SUPPORTS THERACOSBIO WITH INTEGRATED DRUG SUBSTANCE/DRUG PRODUCT PROGRAM FOR BEXAGLIFLOZIN )

Also on site :

• John Legend Celebrates 47th Birthday With Family Slime Outing in New York
• Kurtenbach: These unbelievable 49ers might just be a team of destiny
• United Site Services Reaches Agreement with Key Financial Stakeholders to Position Company for Future Success